Pacira Pharmaceuticals

Company

Investment-firm

Last deal

$242M

Amount

Post-IPO Debt

Stage

10.05.2024

Date

3

all rounds

$354.5M

Total amount

General

About Company
Pacira Pharmaceuticals is a specialty pharmaceutical company focused on postsurgical innovation.

Industry

Sector :

Subsector :

Keywords :

Also Known As

Pacira BioSciences

founded date

01.01.1989

Number of employees

Company Type

For Profit

Last funding type

Post-IPO Debt

IPO status

Private

Description

The San Diego-based Pacira Pharmaceuticals develops and manufactures injectable pharmaceutical products using its proprietary DepoFoam technology. The company's flagship product, EXPAREL, is a non-opioid pain management solution that encapsulates drugs without altering their molecular structure, releasing them over a desired period of time. Pacira Pharmaceuticals is dedicated to advancing and improving outcomes for healthcare practitioners and their patients through regenerative health solutions. The company was founded in 1989 and operates as a subsidiary of Pacira, Inc., formerly known as DepoTech Corp and SkyePharma Inc before changing its name to Pacira Pharmaceuticals Inc. in 2007.
Contacts

Social url